TW202140050A - 使用小韋榮氏球菌進行治療的組成物及方法 - Google Patents

使用小韋榮氏球菌進行治療的組成物及方法 Download PDF

Info

Publication number
TW202140050A
TW202140050A TW110100897A TW110100897A TW202140050A TW 202140050 A TW202140050 A TW 202140050A TW 110100897 A TW110100897 A TW 110100897A TW 110100897 A TW110100897 A TW 110100897A TW 202140050 A TW202140050 A TW 202140050A
Authority
TW
Taiwan
Prior art keywords
veillonella
parvum
total cells
bacterial composition
day
Prior art date
Application number
TW110100897A
Other languages
English (en)
Chinese (zh)
Inventor
馬克 柏德默
安德烈 義塔諾
當肯 麥克海爾
Original Assignee
美商艾弗洛生物科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商艾弗洛生物科技股份有限公司 filed Critical 美商艾弗洛生物科技股份有限公司
Publication of TW202140050A publication Critical patent/TW202140050A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW110100897A 2020-01-10 2021-01-08 使用小韋榮氏球菌進行治療的組成物及方法 TW202140050A (zh)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US202062959454P 2020-01-10 2020-01-10
US62/959,454 2020-01-10
US202063021892P 2020-05-08 2020-05-08
US63/021,892 2020-05-08
US202063071688P 2020-08-28 2020-08-28
US63/071,688 2020-08-28
US202063110603P 2020-11-06 2020-11-06
US63/110,603 2020-11-06
US202063112310P 2020-11-11 2020-11-11
US63/112,310 2020-11-11

Publications (1)

Publication Number Publication Date
TW202140050A true TW202140050A (zh) 2021-11-01

Family

ID=76788749

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110100897A TW202140050A (zh) 2020-01-10 2021-01-08 使用小韋榮氏球菌進行治療的組成物及方法

Country Status (2)

Country Link
TW (1) TW202140050A (fr)
WO (1) WO2021142279A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202233214A (zh) * 2020-11-06 2022-09-01 美商艾弗洛生物科技股份有限公司 使用小韋榮氏球菌細菌誘導免疫效應
KR20230056619A (ko) * 2021-10-20 2023-04-27 주식회사 고바이오랩 항암 활성을 갖는 베일로넬라 파르불라 균주를 이용한 암의 완화, 예방 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
CN105120847B (zh) 2013-03-14 2018-12-28 塞拉拜姆有限责任公司 益生生物和/或治疗剂的靶向胃肠道递送
WO2015095241A2 (fr) * 2013-12-16 2015-06-25 Seres Health, Inc. Compositions bactériennes et leurs méthodes d'utilisation pour traiter des troubles du système immunitaire
CN111148531A (zh) * 2017-09-08 2020-05-12 伊夫罗生物科学公司 细菌胞外囊泡
KR20200118100A (ko) * 2018-02-06 2020-10-14 에벨로 바이오사이언시즈, 인크. 베일로넬라 박테리아를 이용한 암 및 면역 장애를 치료하기 위한 조성물 및 방법

Also Published As

Publication number Publication date
WO2021142279A1 (fr) 2021-07-15

Similar Documents

Publication Publication Date Title
US20220339208A1 (en) Compositions and methods of treating psoriasis and atopic dermatitis using prevotella histicola
US10702561B2 (en) Pharmaceutical compositions comprising a Blautia strain
JP6439037B2 (ja) 細菌株を含む組成物
US20220211773A1 (en) Compositions and methods for treating immune disorders using immune modulating lactococcus bacteria strains
TW202120109A (zh) 使用普雷沃菌屬治療ｔｈ２介導的病症之組成物及方法
TW202302127A (zh) 使用棲組織普雷沃菌治療炎症之組成物及方法
TW202135783A (zh) 包含細菌和微生物胞外囊泡之固體劑型
TW202140051A (zh) 具有改善的崩散譜之固體劑型
WO2019178490A1 (fr) Compositions et procédés pour traiter le cancer et l'inflammation utilisant klebsiella oxytoca
TW202140050A (zh) 使用小韋榮氏球菌進行治療的組成物及方法
TW202228653A (zh) 細菌之固體劑型
TW202227112A (zh) 使用棲組織普雷沃菌治療炎症之組成物及方法
TW202304415A (zh) 含有細菌的藥物製劑
WO2023183396A1 (fr) Compositions et méthodes de traitement d'une inflammation à l'aide de prevotella histicola
WO2023150376A1 (fr) Compositions et procédés pour affecter des niveaux de cytokine à l'aide de prevotella histicola
WO2022098961A1 (fr) Induction d'effets immunitaires à l'aide de bactéries veillonella parvula
WO2023200837A1 (fr) Compositions et méthodes de traitement d'une inflammation à l'aide de prevotella histicola
WO2023239728A1 (fr) Compositions et méthodes de traitement d'une inflammation à l'aide de vésicules extracellulaires de prevotella histicola
TW202322787A (zh) 包含細菌和微生物胞外囊泡之固體劑型